long-term beneficial effects on blood glucose concentrations. Diabetologia 42:45 –50 22.Young AA, Gedulin BR, Bhavsar S, Bodkin N, Jodka C, Hansen B, Denaro M1999 Glucose-lowering and insulin-sensitizing actions of exendin-4. Studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabeticRhesus monkeys ( Macaca mulatta ). Diabetes 48:1026 –1034 23.Gedulin B, Lawler R, Jodka C, Young A 1997 Amylin inhibits pentagastrin- stimulated gastric acid secretion: comparison with glucagon-like peptide-1 andexendin-4. Diabetes 46:188A (Abstract) 24.Nishizawa M, Nakabayashi H, Kawai K, Ito T, Kawakami S, Nakagawa A, Niijima A, Uchida K 2000 The hepatic vagal reception of intraportal GLP-1 is via receptor different from the pancreatic GLP-1 receptor. J Auton Nerv Syst80:14 –21 25.Xu G, Stoffers DA, Habener JF, Bonner-Weir S 1999 Exendin-4 stimulates both /H9252-cell replication and neogenesis, resulting in increased /H9252-cell mass and